The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Parafend 9.06 % Oral Suspension

9.06 percent weight/volume Oral suspension

Norbrook Laboratories (Ireland) LimitedVPA22664/041/001

Main Information

Trade NameParafend 9.06 % Oral Suspension
Active SubstancesOxfendazole
Strength9.06 percent weight/volume
Dosage FormOral suspension
Licence HolderNorbrook Laboratories (Ireland) Limited
Licence NumberVPA22664/041/001

Group Information

ATC CodeQP52AC02 oxfendazole
Therapeutic ClassEndoparasiticide


Withdrawn Date10/02/1994
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back